Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Frontiers in Immunology|June 20, 2019
Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver DiseaseNatalie Stiglund, Kristina Strand, Martin Cornillet, et al.
JHEP Reports : Innovation in Hepatology|January 31, 2024
Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLDCamilla Akbari, Maja Dodd, Per Stål, et al.
Molecular Pharmaceutics|December 21, 2016
In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular CarcinomaElsa Lilienberg, Ilse R Dubbelboer, Amar Karalli, et al.
Hepatology (Baltimore, Md.)|August 7, 2024
Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver diseaseYing Shang, Camilla Akbari, Maja Dodd, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 24, 2022
Liver transplantation in patients with post-hepatectomy liver failure - A Northern European multicenter cohort studyErnesto Sparrelid, Trygve Thorsen, Christina Sauter, et al.
Gut|January 20, 2025
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolationPanagiota Maravelia, Haidong Yao, Curtis Cai, et al.
JHEP Reports : Innovation in Hepatology|February 24, 2026
Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulationsMartin Cornillet, Aiva Lundberg Båve, Dan Sun, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Genome-wide DNA methylation markers associated with metabolic liver cancerSamuel O Antwi, Ampem Darko Jnr Siaw, Sebastian M Armasu, et al.
Gastro Hep Advances|April 25, 2025
Genome-Wide DNA Methylation Markers Associated With Metabolic Liver CancerSamuel O Antwi, Ampem Darko Jnr Siaw, Sebastian M Armasu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2026
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naive Advanced Hepatocellular Carcinoma: Long-Term Follow-Up of Open-Label, Phase 2 KEYNOTE-224 StudyRichard S Finn, Masatoshi Kudo, Ivan Borbath, et al.
Pageof 13